Webmaster
New York, NY—November 21, 2019. Glycotest, Inc., a diagnostics company commercializing new and unique blood tests for life threatening liver cancers and…
Glycotest19-CEOCFOMagazine-Interview.pdf
MedTech Innovator Showcase Announcement 6.17.19
New York, NY—February 14, 2019 Glycotest, Inc., a diagnostics company commercializing new and unique blood tests for life threatening liver cancers and…
New York, NY – 04 January 2018 – Glycotest Inc., announced today that it successfully completed a clinical evaluation of its HCC…
New York, NY— October 05, 2017—Glycotest, Inc. announced today that a Japanese patent protecting fucosylated kininogen—a key biomarker in the Company’s lead…
New York, NY—July 07, 2017—Glycotest, Inc. announced today that a European patent has been granted and additional United States and Australian patents…
London, UK – June 26th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic IP commercialisation group focused on healthcare, provides an update…
Webmaster | Glycotest Diagnostics